Earl sutherland (1915-1975) and the discovery of cyclic AMP

Perspectives in Biology and Medicine

Volumn 55, Issue 2, 2012, Pages 236-249

  Blumenthal, Stanley A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CYCLIC AMP; GLUCAGON; GLUCOSE 1 PHOSPHATE; GLUCOSE PHOSPHATE; GLYCOGEN; HORMONE;

ARTICLE; AWARDS AND PRIZES; GLYCOGENOLYSIS; HISTORY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UNITED STATES;

CYCLIC AMP; EPINEPHRINE; GLUCAGON; GLUCOSEPHOSPHATES; GLYCOGEN; GLYCOGENOLYSIS; HISTORY, 20TH CENTURY; HORMONES; NOBEL PRIZE; PHYSIOLOGY; SIGNAL TRANSDUCTION; UNITED STATES;

EID: 84861129508     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2012.0017     Document Type: Article

References (51)

1. Bos, J. L., H. Rehmann, and A. Wittinghofer. 2007. GEFS and GAPS: Critical elements in the control of small G proteins. Cell 129:865-77.
2. Boswell-Smith, V., D. Spina, and C. P. Page. 2006. Phosphodiesterase inhibitors. Br J Pharmacol 147:S252-S257.
3. Brunton, L. L., et al. 2008. Drugs affecting renal and cardiovascular function. In Manual of pharmacology and therapeutics, ed. L. L. Brunton, et al., 538-42, 575. NewYork:Mc-Graw-Hill.
4. Butcher, R.W., and G.A. Robison. 1975.An appreciation of Earl Sutherland.Metabolism 24:237-40.
5. Conkright, M. D., and M. Montminy. 2005. CREB:The unindicted cancer co-conspirator. Trends Cell Biol 15:457-59.
6. Cook, W.H., D. Lipkin, and R. Markham. 1957.The formation of a dianhydrodiadenylic acid (I) by the alkaline degradation of adenosine-5'-triphosphoric acid (II). J Am Chem Soc 79:3607-8
7. Cori, C. F., and G.T. Cori. 1936.Mechanism of formation of hexosemonophosphate in muscle and isolation of a new phosphate ester. Proc Soc Exp Biol Med 34:702-5.
8. Cori, C. F., and G.T. Cori. 1947. Polysaccharide phosphorylase. In Nobel lectures, physiology or medicine 1942-1962, 186-206.Amsterdam: Elsevier.
9. Danforth, W.H., E. Helmreich, and C. F. Cori. 1962.The effect of contraction and of epinephrine on the phosphorylase activity of frog sartorius muscle. Proc Natl Acad Sci 48: 1191-99.
10. Fischer, E. H. 1992. Protein phosphorylation and cellular regulation II. In Nobel lectures, physiology or medicine 1991-1995, ed.N.Ringertz, 95-113. Singapore:World Scientific Publishing Company.
11. Follin-Arbelet, V., et al. 2011. Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. Cancer 11:301-10.
12. Fruton, J. S. 1972. Glucose and glycogen in the animal body. In Molecules and life, 405. NewYork: JohnWiley.
13. Gallagher, G. L. 1990. Getting the message across. J NIH Res 2:77-78.
14. Gilman,A. G. 1984. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J Clin Invest 73:1-4.
15. Gilman, A. G. 1994. G proteins and regulation of adenylyl cyclase. In Nobel lectures, physiology or medicine 1991-1995, ed. N. Ringertz, 182-212. Singapore:World Scientific Publishing Company.
16. Gonzalez, G.A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of creb at serine 133. Cell 59:675-80.
17. Greengard, P. 2000.The neurobiology of dopamine signaling. In Nobel lectures, physiology or medicine 1996-2000, ed.H. Jornvall, 328-47. Singapore:World Scientific Publishing Company.
18. Keller, P. J., and G.T. Cori. 1953. Enzymic conversion of phosphorylase a to phosphorylase b. Biochim Biophys Acta 12:235-38.
19. Krebs, E. G. 1992. Protein phosphorylation and cellular regulation I. In Nobel lectures, physiology or medicine 1991-1995, ed. N. Ringertz, 75. Singapore:World Scientific Publishing Company.
20. Krebs, E. G., and E. H. Fischer. 1956.The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim Biophys Acta 20:150-57.
21. Leloir, L. F., and C. E. Cardini. 1957. Biosynthesis of glycogen from uridine diphosphate glucose. J Am Chem Soc 79:6340-41.
22. Mayr, B. M., G. Canettieri, and M. R. Montminy. 2001. Distinct effects of camp and mitogenic signals on creb-binding protein recruitment impart specificity to target gene activation via creb. Proc Natl Acad Sci USA 98:10936-41.
23. Medina, A. E. 2011.Therapeutic utility of phosphodiesterase type I inhibitors in neurological conditions. Front Neurosci 5:1-5.
24. Mei, F. C., et al. 2002. Differential signaling of cyclic AMP. J Biol Chem 277:11497-504.
25. Nairn, A. C., et al. 2004.The role of DARPP-32 in the actions of drugs of abuse. Neuropharmacology 47:14-23.
26. Neves, S. R., P. T. Ram, and R. Iyengar. 2002. G protein pathways. Science 296:1636-39.
27. Parma, J., et al. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-51.
28. Pietrobon, M. et al. 2011. Interplay among cGMP, cAMP, and Ca++ in living olfactory sensory neurons in vitro and in vivo. J Neurosci 31:8395-405.
29. Rall, T.W. 1975.On the importance of cyclic AMP in neurobiology: An essay.Metabolism 24:241-48.
30. Rall, T.W., and E.W. Sutherland. 1958. Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 232:1065-76.
31. Rall, T.W., E.W. Sutherland, and J. Berthet. 1957.The relationship of epinephrine and glucagon to liver phosphorylase IV. The effect of epinephrine and glucagon on the reactivation of phosphorylase in liver homogenates. J Biol Chem 224:463-75.
32. Rall, T.W., E.W. Sutherland, and W. D. Wosilait. 1956.The relationship of epinephrine and glucagon to liver phosphorylase III. Reactivation of liver phosphorylase in slices and in extracts. J Biol Chem 218:483-95.
33. Ringel, M. D., W. F. Schwindinger, and M. A. Levine. 1996. Clinical implications of genetic defects in G proteins:The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine 75:171-84.
34. Rodbell, M. 1994. Signal transduction: evolution of an idea. In Nobel lectures, physiology or medicine 1991-1995, ed. N. Ringertz, 220-37. Singapore:World Scientific Publishing Company.
35. Shenker, A., et al. 1993.A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-54.
36. Soderling, T. R., et al. 1970. Inactivation of glycogen synthetase and activation of phosphorylase kinase by muscle adenosine 3',5'-monophosphate-dependent protein kinases. J Biol Chem 245:6317-28.
37. Stratakis, C.A., L. S. Kirschner, and J.A. Carney. 2001. Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. J Clin Endocrinol Metab 86:4041-46.
38. Sutherland, E.W. 1971. Studies on the mechanism of hormone action. In Nobel lectures, physiology or medicine 1971-1980, ed. J. Lindsten, 5-22. Singapore:World Scientific Publishing Company.
39. Sutherland, E.W., S. P. Colowick, and C. F. Cori. 1941.The enzymatic conversion of glucose-6-phosphate to glycogen. J Biol Chem 140:309-10.
40. Sutherland, E.W., and C. F. Cori. 1948. Influence of insulin preparations on glycogenolysis in liver slices. J Biol Chem 172:737-50.
41. Sutherland, E.W., and C. F. Cori. 1951. Effect of hyperglycemic-glycogenolytic factor and epinephrine on liver phosphorylase. J Biol Chem 188:531-43.
42. Sutherland, E.W., and C. de Duve 1948. Origin and distribution of the hyperglycemicglycogenolytic factor of the pancreas. J Biol Chem 175:663-74.
43. Sutherland, E.W., and T.W. Rall. 1957.The properties of an adenine ribonucleotide produced with cellular particles,ATP, Mg++, and epinephrine or glucagon. J Am Chem Soc 79:3608.
44. Sutherland, E.W., and T.W. Rall. 1958. Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem 232:1077-91.
45. Sutherland, E.W., T.W. Rall, and T. Menon. 1962.Adenyl Cyclase I: Distribution, preparation, and properties. J Biol Chem 237:1220-27.
46. Sutherland, E.W., and G.A. Robison. 1966. Metabolic effects of catecholamines A:The role of cyclic-3',5'- AMP in responses to catecholamines and other hormones. Pharmacol Rev 18:145-61.
47. Sutherland, E.W., G.A. Robison, and R.W. Butcher. 1968. Some aspects of the biological role of adenosine 3',5' monophosphate (cyclic AMP). Circulation 37:279-306.
48. Sutherland, E.W., and W.D. Wosilait. 1956.The relationship of epinephrine and glucagon to liver phosphorylase I. Liver phosphorylase; preparation and properties. J Biol Chem 218:459-68.
49. Sutherland, E.W., et al. 1949. Purification of the hyperglycemic-glycogenolytic factor from insulin and from gastric mucosa. J Biol Chem 180:825-37.
50. Tesmer, J. J. G. 2008. Guanylyl cyclase sees the light. J Biol 7:31.
51. Wosilait, W.D., and E.W. Sutherland. 1956.The relationship of epinephrine and glucagon to liver phosphorylase. II. Enzymatic inactivation of liver phosphorylase. J Biol Chem 218:469-81.